| Trial | Updated / Type |
Status | Phase | Were Results Reported |
Reported Actual Enrollment |
(MeSH) Terms |
Why Stopped
Limitations And Caveats |
Annotator decisions |
|---|---|---|---|---|---|---|---|---|
| NCT02644473 Details | 2018-05-31 Interventional | 4 | 0 | Tranexamic Acid Embolism Infarction Myocardial Infa… Pulmonary Embol… Thrombosis Venous Thrombos… Deep Vein Throm… Stroke | Study did not receive IRB approval, so did not start - | |||
| NCT00827580 Details | 2018-05-30 Interventional | 1 | 3 | Eniluracil Colonic Neoplas… Hand-Foot Syndr… Breast Cancer Colon Cancer | - - | |||
| NCT02381548 Details | 2018-05-25 Interventional | 1 | 20 | Adavosertib Belinostat Blast Crisis Leukemia Leukemia, Myelo… Leukemia, Myelo… Leukemia, Myelo… Myelodysplastic… Preleukemia Recurrence Syndrome Acute Myeloid L… Blast Phase Chr… Myelodysplastic… Previously Trea… Recurrent Adult… Recurrent Chron… Refractory Acut… Refractory Chro… Secondary Acute… Therapy-Related… Untreated Adult… | - - | |||
| NCT02666365 Details | 2018-05-24 Interventional | 4 | 0 | Cefazolin Surgical Wound … Surgical Site I… | Investigator decided not to proceed. - | |||
| NCT02448550 Details | 2018-05-24 Interventional | 3 | 250 | Bivalirudin Calcium heparin Heparin Percutaneous Co… | - - | |||
| NCT03023527 Details | 2018-05-23 Interventional | 1 | 6 | Dexamethasone Elotuzumab Nivolumab Pomalidomide Multiple Myelom… Neoplasms, Plas… | Safety - | |||
| NCT02057289 Details | 2018-05-23 Interventional | 1 | 9 | Micafungin Bone Marrow Tra… Cancer Immunocompromis… | - - | |||
| NCT01522443 Details | 2018-05-23 Interventional | 3 | 119 | Mitoxantrone Prednisone Prostatic Neopl… Castration Resi… Pain Prostate Cancer | Stopped after the outcome of cabozantinib Phase 3 CRPC study XL184-307. Enrollment was stopped before planned study population size of 246 was reached (only 119 enrolled). | |||
| NCT00212004 Details | 2018-05-23 Interventional | 4 | 630 | Pioglitazone Diabetes Mellit… Infarction Myocardial Infa… | Limited budget to continue this study - | |||
| NCT03119077 2016-003520-23 Details | 2018-05-17 Interventional | 1 | 32 | Itraconazole Polycystic Ovar… | Study early terminated due to lower drug exposure - | |||
| NCT02609152 2015-000895-90 Details | 2018-05-17 Interventional | 3 | 0 | Esmolol Shock Shock, Septic | logistical difficulties - | |||
| NCT01471964 Details | 2018-05-17 Interventional | 1/2 | 22 | Erlotinib Hydro… Carcinoma, Non-… Lung Neoplasms Non-small Cell … Non-small Cell … | Phase I portion completed. Phase II will open pending amendment approval. - | |||
| NCT01382706 Details | 2018-05-16 Interventional | 2 | 15 | Docetaxel Lapatinib Carcinoma Carcinoma, Tran… Urinary Bladder… Recurrent Bladd… Stage III Bladd… Stage IV Bladde… Transitional Ce… | Trial not progressing toward scientific goals - | |||
| NCT01200589 Details | 2018-05-16 Interventional | 3 | 438 | Antibodies, Mon… Ofatumumab Rituximab Lymphoma Lymphoma, B-Cel… Lymphoma, Non-H… Non-Hodgkin's L… | The study stopped due to futility. - | |||
| NCT01025648 Details | 2018-05-16 Interventional | 1/2 | 9 | Epinephrine Epinephryl bora… Racepinephrine Asthma | Optimization of protocol - | |||
| NCT02013791 Details | 2018-05-15 Interventional | 2 | 55 | Cyclosporine Cyclosporins Dry Eye Syndrom… Eye Diseases Keratoconjuncti… | - - | |||
| NCT02820493 Details | 2018-05-14 Interventional | 4 | 0 | Vedolizumab Crohn Disease | Internal problems - | |||
| NCT02635074 Details | 2018-05-14 Interventional | 1 | 2 | Cytarabine Ibrutinib Idarubicin Leukemia Leukemia, Myelo… Leukemia, Myelo… Recurrent Adult… | safety - | |||
| NCT02372240 Details | 2018-05-11 Interventional | 1/2 | 15 | Dexamethasone Multiple Myelom… Neoplasms, Plas… | Dose limiting tox is observed. Study put on full clinical hold. - | |||
| NCT01804777 Details | 2018-05-11 Interventional | 1 | 9 | Amiloride Hydrochlorothia… Diabetes Mellit… Diabetes Mellit… Hypertension Proteinuria Type II Diabete… | Currently closed for data analysis. - |